ARMCX3 Human Pre-designed siRNA Set A contains three designed siRNAs for ARMCX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARMCX4 Human Pre-designed siRNA Set A contains three designed siRNAs for ARMCX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARMS2 Human Pre-designed siRNA Set A contains three designed siRNAs for ARMS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model[1].

ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model[1].

ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model[1].

ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model[1].

ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model[1].

ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model[1].

ARNT Human Pre-designed siRNA Set A contains three designed siRNAs for ARNT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARNT2 Human Pre-designed siRNA Set A contains three designed siRNAs for ARNT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Arotinoid (RO 13-6298) is a retinoid, and acts as an orally active and highly potent agonist of retinoic acid receptors (RARs) with antipsoriatic effects. Arotinoid has antipapiltoma activity with an ED50 of 0.05 mg/kg. Arotinoid can be used for the research of skin carcinomas[1][2].

ARP (Aldehyde reactive probe) is an aldehyde reactive probe for detecting abasic site (common DNA lesions and intermediates in mutagenesis and carcinogenesis) in DNA, which specificially tags AP site with biotin residues. ARP is highly sensitive with a femtomolar-level basic site detection capabilities (less than one site per 104 nucleotides)[1].

ARPC1A Human Pre-designed siRNA Set A contains three designed siRNAs for ARPC1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARPC1B Human Pre-designed siRNA Set A contains three designed siRNAs for ARPC1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARPC2 Human Pre-designed siRNA Set A contains three designed siRNAs for ARPC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Arpc2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Arpc2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Arpc2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Arpc2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARPC3 Human Pre-designed siRNA Set A contains three designed siRNAs for ARPC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Arpc3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Arpc3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Arpc3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Arpc3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARPC4 Human Pre-designed siRNA Set A contains three designed siRNAs for ARPC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARPC5 Human Pre-designed siRNA Set A contains three designed siRNAs for ARPC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARPC5L Human Pre-designed siRNA Set A contains three designed siRNAs for ARPC5L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Arphamenine B (hemisulfate) is a Zn2+-dependent exopeptidase that selectively removes arginine and/or lysine residues from the NH2-terminus of several peptide substrates. Arphamenine B (hemisulfate) Arphamenine B (hemisulfate) is an inhibitor of aminopeptidase B that can be isolated from bacteria. Arphamenine B (hemisulfate) enhances the immune response and is used to characterize novel proteases[1][2][3].

ARPIN Human Pre-designed siRNA Set A contains three designed siRNAs for ARPIN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARPP19 Human Pre-designed siRNA Set A contains three designed siRNAs for ARPP19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARPP21 Human Pre-designed siRNA Set A contains three designed siRNAs for ARPP21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARR3 Human Pre-designed siRNA Set A contains three designed siRNAs for ARR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARRB1 Human Pre-designed siRNA Set A contains three designed siRNAs for ARRB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARRB2 Human Pre-designed siRNA Set A contains three designed siRNAs for ARRB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARRDC1 Human Pre-designed siRNA Set A contains three designed siRNAs for ARRDC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARRDC2 Human Pre-designed siRNA Set A contains three designed siRNAs for ARRDC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARRDC3 Human Pre-designed siRNA Set A contains three designed siRNAs for ARRDC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARRDC4 Human Pre-designed siRNA Set A contains three designed siRNAs for ARRDC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers[1].

ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers[1].

ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers[1].

ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers[1].

ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers[1].

ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers[1].

ARSA Human Pre-designed siRNA Set A contains three designed siRNAs for ARSA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARSB Human Pre-designed siRNA Set A contains three designed siRNAs for ARSB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARSD Human Pre-designed siRNA Set A contains three designed siRNAs for ARSD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARSF Human Pre-designed siRNA Set A contains three designed siRNAs for ARSF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARSG Human Pre-designed siRNA Set A contains three designed siRNAs for ARSG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARSH Human Pre-designed siRNA Set A contains three designed siRNAs for ARSH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARSI Human Pre-designed siRNA Set A contains three designed siRNAs for ARSI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.